Red Light Therapy for Near-Sightedness
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this clinical trial is to see if and how well Repeated Low-Level Red Light (RLRL) therapy works to control myopia over 12 months. The main question it aims to answer is:
* Can RLRL therapy help slow down the worsening of myopia?
Participants will use a red-light therapy investigational device at home, 5 days a week for 12 months.
Who Is on the Research Team?
Yasmin Bradfield, MD
Principal Investigator
University of Wisconsin, Madison
Are You a Good Fit for This Trial?
This trial is for people with near-sightedness (myopia), astigmatism, or anisometropia. Participants should be able to use a home device as instructed and meet other basic health requirements set by the study team.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Repeated Low-Level Red Light (RLRL) therapy
Trial Overview
The study tests whether using a repeated low-level red light (RLRL) therapy device at home can slow down worsening of myopia over 12 months, compared to a placebo device. Participants are randomly assigned to either group.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Participants will receive red light therapy
Participants will receive placebo therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.